These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 2823191)

  • 1. Ubiquitin-protein conjugates in Alzheimer's lesions.
    Cole GM; Timiras PS
    Neurosci Lett; 1987 Aug; 79(1-2):207-12. PubMed ID: 2823191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of neurofibrillary degeneration in Alzheimer's disease. An immunohistochemical study.
    Bondareff W; Wischik CM; Novak M; Amos WB; Klug A; Roth M
    Am J Pathol; 1990 Sep; 137(3):711-23. PubMed ID: 2169192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A monoclonal antibody to non-phosphorylated neurofilament protein marks the vulnerable cortical neurons in Alzheimer's disease.
    Morrison JH; Lewis DA; Campbell MJ; Huntley GW; Benson DL; Bouras C
    Brain Res; 1987 Jul; 416(2):331-6. PubMed ID: 3113670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunohistochemical evidence for reorganization of tau in the plaques and tangles in Alzheimer's disease.
    Wood JG; Zinsmeister P
    Histochem J; 1989 Nov; 21(11):659-62. PubMed ID: 2511165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Saccharides of senile plaques and neurofibrillary tangles in Alzheimer's disease.
    Mann DM; Bonshek RE; Marcyniuk B; Stoddart RW; Torgerson E
    Neurosci Lett; 1988 Feb; 85(2):277-82. PubMed ID: 3374842
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isolation and partial characterization of neurofibrillary tangles and amyloid plaque core in Alzheimer's disease: immunohistological studies.
    Gorevic PD; Goñi F; Pons-Estel B; Alvarez F; Peress NS; Frangione B
    J Neuropathol Exp Neurol; 1986 Nov; 45(6):647-64. PubMed ID: 3772397
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer's disease: glycolytic pretreatment dramatically enhances immunolabeling of senile plaques and cerebrovascular amyloid substance.
    Behrouz N; Defossez A; Delacourte A; Hublau P; Mazzuca M
    Lab Invest; 1989 Nov; 61(5):576-83. PubMed ID: 2478759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Senile plaque neurites in Alzheimer disease accumulate amyloid precursor protein.
    Cras P; Kawai M; Lowery D; Gonzalez-DeWhitt P; Greenberg B; Perry G
    Proc Natl Acad Sci U S A; 1991 Sep; 88(17):7552-6. PubMed ID: 1652752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease: neurofibrillary tangles in nuclei that project to the cerebral cortex.
    German DC; White CL; Sparkman DR
    Neuroscience; 1987 May; 21(2):305-12. PubMed ID: 3302759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased somatostatin immunoreactivity but not neuropeptide Y immunoreactivity in cerebral cortex in senile dementia of Alzheimer type.
    Dawbarn D; Rossor MN; Mountjoy CQ; Roth M; Emson PC
    Neurosci Lett; 1986 Sep; 70(1):154-9. PubMed ID: 2877420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibrillary tangles in dementia pugilistica are ubiquitinated.
    Dale GE; Leigh PN; Luthert P; Anderton BH; Roberts GW
    J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):116-8. PubMed ID: 1850450
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The widespread alteration of neurites in Alzheimer's disease may be unrelated to amyloid deposition.
    Tabaton M; Mandybur TI; Perry G; Onorato M; Autilio-Gambetti L; Gambetti P
    Ann Neurol; 1989 Dec; 26(6):771-8. PubMed ID: 2557796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alzheimer's disease: mismatch between amyloid plaques and neuritic plaques.
    Braak H; Braak E; Ohm T; Bohl J
    Neurosci Lett; 1989 Aug; 103(1):24-8. PubMed ID: 2476692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical studies: an update on Alzheimer's disease.
    Davies P
    J Clin Psychiatry; 1988 May; 49 Suppl():23-8. PubMed ID: 2836376
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ubiquitin is detected in neurofibrillary tangles and senile plaque neurites of Alzheimer disease brains.
    Perry G; Friedman R; Shaw G; Chau V
    Proc Natl Acad Sci U S A; 1987 May; 84(9):3033-6. PubMed ID: 3033674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A4 amyloid protein immunoreactivity is present in Alzheimer's disease neurofibrillary tangles.
    Hyman BT; Van Hoesen GW; Beyreuther K; Masters CL
    Neurosci Lett; 1989 Jul; 101(3):352-5. PubMed ID: 2671814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tau antisera recognize neurofibrillary tangles in a range of neurodegenerative disorders.
    Joachim CL; Morris JH; Kosik KS; Selkoe DJ
    Ann Neurol; 1987 Oct; 22(4):514-20. PubMed ID: 2963585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease.
    Selkoe DJ; Abraham CR; Podlisny MB; Duffy LK
    J Neurochem; 1986 Jun; 46(6):1820-34. PubMed ID: 3517233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ubiquitin is a component of neurofibrillary tangles in a variety of neurodegenerative diseases.
    Lennox G; Lowe J; Morrell K; Landon M; Mayer RJ
    Neurosci Lett; 1988 Nov; 94(1-2):211-7. PubMed ID: 2853854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased Mr 60,000 protein phosphorylation is correlated with neocortical neurofibrillary tangles in Alzheimer's disease.
    Saitoh T; Hansen LA; Dobkins KR; Terry RD
    J Neuropathol Exp Neurol; 1988 Jan; 47(1):1-8. PubMed ID: 3334725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.